Pharmaron Acquires Bioprocessing Site from AbbVie
Pharmaron Acquires Bioprocessing Site from AbbVie Source: ljubaphoto/Getty Images March 5, 2021 Pharmaron, an R&D service provider for the life sciences industry with operations in China, the U.S., and the U.K., reports that it has entered into an agreement to acquire Allergan Biologics (ABL) in Liverpool from AbbVie for $118.7 million in cash. The deal is set to close in the second quarter of 2021. The ABL site consists of a cGMP biomanufacturing facility that has held MHRA biologic manufacturing license accreditation since 2007. The deal comes four months after Pharmaron announced its acqu...
Source: genengnews.com